Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2023-07-12 00:00:00 ET · period of report 2023-05-26 · accession 0001140361-23-034282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-12 | 2023-05-26 | RIGL | HANNAH ALISON L. | Dir | A - Grant | $0.00 | +25.0K | 56.2K | +80% | $0 |
| D | 2023-07-12 | 2023-05-26 | RIGL | HANNAH ALISON L. | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-26 | A | A | 25,000 | $0.00 | 56,250 | D | — | — | (F1) The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-26 | A | A | 30,000 | $0.00 | 30,000 | D | $1.32 · — to 2033-05-26 | 30,000 Common Stock | (F2) The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. |